ð ãã³ãããã¯åŸãç¶ãåã©ãã®è¥æºåé¡ïŒãã©ã³ã¹ããã®å ±å
COVID-19ãã³ãããã¯ã¯ç§ãã¡ã®ç掻ã«å€§ããªå€åããããããŸãããããã®åœ±é¿ã¯åã©ãã®å¥åº·ã«ãåãã§ããŸããç¹ã«ãåã©ãã®è¥æºãéäœéã¯äžççãªå¥åº·èª²é¡ã§ããããã³ãããã¯ããã®åé¡ã«ã©ã®ãããªåœ±é¿ãäžããã®ãã¯éèŠãªé¢å¿äºã§ããæ¬èšäºã§ã¯ããã©ã³ã¹åéšã§è¡ããã3ã5æ³å ã®è¥æºãšéäœéã«é¢ããææ°ã®ç ç©¶çµæãã玹ä»ãããã®èæ¯ã«ãã瀟äŒçãªèŠå ããç§ãã¡ãæ¥åžžç掻ã§ã§ããããšã«ã€ããŠæ·±ãæãäžããŠãããŸãã
ð ç ç©¶ã®æŠèŠ
äžçè¥æºé£çã¯ã5æ³ãŸã§ã«2å600äžäººã®åã©ããè¥æºã®åœ±é¿ãåãããšæšå®ããŠãããåã©ãã®è¥æºã¯äžççãªå ¬è¡è¡çäžã®èª²é¡ãšãªã£ãŠããŸãããã©ã³ã¹åéšã§ã¯ã2017幎ãã2020幎ã®éã«3ã5æ³å ã®éäœéãŸãã¯è¥æºã®æç çã11.7%ã«éããç¹ã«ç€ŸäŒçµæžçã«äžå©ãª3ã€ã®å°åºã§ã¯16%ã«ãäžã£ãŠããŸããã
ãã®ç ç©¶ã®ç®çã¯ãCOVID-19ãã³ãããã¯åŸã®ç¶æ³ãææ¡ããããããã©ã³ã¹åéšã®ããŒã·ã¥ïŒãã¥ïŒããŒãçã«ããã2022-2023åŠå¹ŽåºŠã®3ã5æ³å ã®éäœéããã³è¥æºã®æç çãè©äŸ¡ããããšã§ãããç¹ã«ã以åããé«ãæç çãå ±åãããå°åçãªè¥æºäºé²çãå±éãããŠãã3ã€ã®äžå©ãªå°åºã«çŠç¹ãåœãŠããã®ç¶æ³ã詳ãã調æ»ããŸããã
ð¬ ç ç©¶ã®æ¹æ³
ãã®ç ç©¶ã¯ãç¹å®ã®æç¹ã§ã®ç¶æ³ãèšè¿°ãããèšè¿°çãæšªæç ç©¶ããšããŠå®æœãããŸããã察象ãšãªã£ãã®ã¯ã2022-2023åŠå¹ŽåºŠã«ç³»çµ±çãªå¥åº·èšºæãåãã幌çšåå ãã¡ã§ãã
察象è ãšããŒã¿åé
- 察象è ïŒ 2022-2023åŠå¹ŽåºŠã«ãã©ã³ã¹åéšã®ããŒã·ã¥ïŒãã¥ïŒããŒãçã§ç³»çµ±çãªå¥åº·èšºæãåãã3ã5æ³ã®å¹Œçšåå ã
- æž¬å®ææšïŒ 身é·ãšäœéãæž¬å®ããåœéè¥æºã¿ã¹ã¯ãã©ãŒã¹ïŒInternational Obesity Task ForceïŒã®åºæºãçšããŠãå¹Žéœ¢ãšæ§å¥ãèæ
®ããäœæ Œææ°ã§ãããBMI Zã¹ã³ã¢ããç®åºããŸããã
- ç°¡ææ³šéïŒBMI Zã¹ã³ã¢ãšã¯ãå¹Žéœ¢ãæ§å¥ãèæ ®ããåã©ãã®äœæ Œææ°ïŒBMIïŒã®æšæºåå·®å€ã§ãåã©ãã®æé·æ®µéã«å¿ããè¥æºåºŠãè©äŸ¡ããããã«çšããããŸããInternational Obesity Task ForceïŒåœéè¥æºã¿ã¹ã¯ãã©ãŒã¹ïŒã¯ãåã©ãã®è¥æºãåœéçã«æ¯èŒããããã®åºæºãå®ããŠããŸãã
- 瀟äŒçèŠå ïŒ ååŠåºã®ç€ŸäŒçµæžçãªäžå©ãã瀺ãããã©ã³ã¹å¥å¥ªææ°ïŒFDep indexïŒãã®ããŒã¿ãåéãã瀟äŒçäžå¹³çãè¥æºã«äžãã圱é¿ãè©äŸ¡ããŸããã
- ç°¡ææ³šéïŒãã©ã³ã¹å¥å¥ªææ°ïŒFDep indexïŒãšã¯ã瀟äŒçµæžçãªäžå©ããç€ºãææšã§ãæåŸãæè²ãéçšãå± äœç°å¢ãªã©ã®èŠçŽ ãçµã¿åãããŠç®åºãããŸããææ°ãé«ãã»ã©ããã®å°åãäœæ°ã瀟äŒçã«äžå©ãªç¶æ³ã«ããããšã瀺ããŸãã
çµ±èšåæ
- éäœéããã³è¥æºã®æç
çãšãæ§å¥ãåŠåºã®é¢é£æ§ãè©äŸ¡ããããã«ããã«ã€äºä¹æ€å®ãã䜿çšãããŸããã
- ç°¡ææ³šéïŒã«ã€äºä¹æ€å®ãšã¯ã2ã€ä»¥äžã®ã«ããŽãªã«ã«å€æ°ïŒäŸãã°ãæ§å¥ãšè¥æºã®æç¡ïŒã®éã«çµ±èšçã«ææãªé¢é£ããããã©ããã調ã¹ãçµ±èšææ³ã§ãã
ð äž»ãªç ç©¶çµæ
ãã®ç ç©¶ã«ã¯åèš13,454人ã®åã©ããã¡ãåå ããŸãããå¹³å幎霢ã¯48ã¶æïŒ4æ³ïŒã§ãå¹³åBMI Zã¹ã³ã¢ã¯-0.05 ± 1.16ã§ããã
| é ç® | çµæ | 詳现 |
|---|---|---|
| å šäœã®éäœéæç ç | 8.5% | ïŒ95%ä¿¡é Œåºé [7.6;9.3]ïŒ |
| å šäœã®è¥æºæç ç | 2.5% | ïŒ95%ä¿¡é Œåºé [1.6;3.3]ïŒ |
| æ§å¥ã«ããéäœéã®å·® | 女æ§ã§ææã«é«ã | å¥³æ§ 9.7%ïŒ95% CI [8.5;10.9]ïŒ vs ç·æ§ 7.2%ïŒ95% CI [6.0;8.4]ïŒïŒp<0.001 |
| 瀟äŒçµæžçæ Œå·®ïŒFDepææ°ïŒã®åœ±é¿ | FDepææ°ãé«ãã»ã©éäœéæç çãå¢å | |
| äžå©ãª3å°åºã§ã®éäœéæç ç | 11.4% | ïŒå°åçãªè¥æºäºé²çãå±éãããŠããå°åºïŒ |
| äžå©ãª3å°åºã§ã®è¥æºæç ç | 4.5% | çå šäœïŒ2.5%ïŒãšæ¯èŒããŠææã«é«ãã£ãïŒp<0.001ïŒ |
ð¡ èå¯ïŒäœããã®çµæãæå³ããã®ãïŒ
ãã®ç ç©¶çµæã¯ãCOVID-19ãã³ãããã¯åŸããã©ã³ã¹åéšã®3ã5æ³å ã«ãããéäœéãšè¥æºã®æç çãå®å®ããŠé«ãæ°Žæºã«ããããšã瀺ããŠããŸããããã¯ããã³ãããã¯ãåã©ãã®è¥æºåé¡ã«åçãªå€åããããããããã§ã¯ãªããã®ã®ã以åããååšããŠããåé¡ãäŸç¶ãšããŠç¶ç¶ããŠããããšã瀺åããŠããŸãã
æ§å·®ã®éèŠæ§
ç¹ã«æ³šç®ãã¹ãã¯ãéäœéã®æç çã女æ§ã§ææã«é«ãã£ãç¹ã§ããããã¯ãåã©ãã®è¥æºå¯Ÿçãèããäžã§ãæ§å¥ã«ããéããèæ ®ããå¿ èŠãããããšã瀺åããŠããŸããè¡åæ§åŒããã«ã¢ã³ã®åœ±é¿ãèº«äœæŽ»åã¬ãã«ããããã¯ç€ŸäŒçãªæåŸ ãªã©ãæ§å·®ã«åœ±é¿ãäžããŠããå¯èœæ§ãããããããªã詳现ãªç ç©¶ãæ±ããããŸãã
瀟äŒçµæžçæ Œå·®ã®æ·±å»ãªåœ±é¿
ãŸãããã©ã³ã¹å¥å¥ªææ°ïŒFDep indexïŒãé«ããã€ãŸã瀟äŒçµæžçã«äžå©ãªå°åã»ã©ãéäœéãè¥æºã®æç çãé«ãããšãæããã«ãªããŸãããç¹ã«ã以åããåé¡ãææãããå°åçãªä»å ¥çã宿œãããŠãã3ã€ã®äžå©ãªå°åºã§ã¯ãè¥æºã®æç çãçå šäœã®çŽ2åã«éããŠããŸãããããã¯ãå¥åº·çãªé£åãžã®ã¢ã¯ã»ã¹ãå®å šãªéã³å Žã®äžè¶³ãå¥åº·æè²ã®æ©äŒã®å°ãªãã芪ã®ã¹ãã¬ã¹ã¬ãã«ã®é«ããªã©ã瀟äŒçµæžçãªèŠå ãåã©ãã®å¥åº·ã«è€åçã«åœ±é¿ããŠããããšã匷ã瀺åããŠããŸãã
ãããã®çµæã¯ãåã©ãã®è¥æºåé¡ãåãªãå人ã®é£ç掻ãéåç¿æ £ã®åé¡ã§ã¯ãªãã瀟äŒå šäœã§åãçµãã¹ãè€éãªèª²é¡ã§ããããšãæµ®ã圫ãã«ããŠããŸããç¹ã«ã瀟äŒçµæžçã«äžå©ãªç¶æ³ã«ããåã©ããã¡ãžã®æ¯æŽã匷åããå°å瀟äŒå šäœã§å¥åº·çãªç°å¢ãæŽåããŠããããšã®éèŠæ§ãå確èªãããŸããã
ð¡ å®ç掻ã§ã§ããããšïŒåã©ãã®å¥åº·ãå®ãããã«
ãã®ç ç©¶çµæãèžãŸããç§ãã¡äžäººã²ãšããåã©ãã®å¥åº·ãå®ãããã«ã§ããããšã¯äœã§ãããããå®¶åºãå°å瀟äŒã§å®è·µã§ããå ·äœçãªã¢ããã€ã¹ã以äžã«ç€ºããŸãã
- ãã©ã³ã¹ã®åããé£äºãå¿ãããïŒ
- éèãæç©ãå šç²ç©ç©ãç©æ¥µçã«é£åã«åãå ¥ããŸãããã
- å å·¥é£åãç³åã®å€ã飲æãé«èèªã®ã¹ããã¯èåã¯æ§ããã«ããŸãããã
- å®¶æã§äžç·ã«é£äºãæºåããé£è²ã®æ©äŒãå¢ãããŸãããã
- ååãªèº«äœæŽ»åã奚å±ããïŒ
- æ¯æ¥å°ãªããšã60åã¯ãå€éã³ãã¹ããŒããªã©ãäœãåããæ©äŒãèšããŸãããã
- å ¬åãåºå Žãªã©ãå®å šã«éã¹ãå Žæãç©æ¥µçã«å©çšããŸãããã
- å®¶æã§äžç·ã«æ£æ©ããµã€ã¯ãªã³ã°ã楜ãããªã©ãäœãåããç¿æ £ãäœããŸãããã
- ã¹ã¯ãªãŒã³ã¿ã€ã ãé©åã«ç®¡çããïŒ
- ãã¬ããã¿ãã¬ãããã¹ããŒããã©ã³ã®äœ¿çšæéãå¶éãã幎霢ã«å¿ããã¬ã€ãã©ã€ã³ãåèã«ããŸãããã
- ã¹ã¯ãªãŒã³ãèŠãæéããåµé çãªéã³ãèªæžã®æéã«çœ®ãæããŸãããã
- èŠåæ£ããçæŽ»ãªãºã ã確ç«ããïŒ
- ååãªç¡ç æéã確ä¿ããèŠåæ£ããå°±å¯ã»èµ·åºæéãå®ããŸãããã
- èŠåæ£ããçæŽ»ã¯ã飿¬²ããšãã«ã®ãŒæ¶è²»ã®ãã©ã³ã¹ãæŽããã®ã«åœ¹ç«ã¡ãŸãã
- å®¶æå
šäœã§å¥åº·çãªç¿æ
£ãå®è·µããïŒ
- 芪ãä¿è·è ãå¥åº·çãªé£ç掻ãéåç¿æ £ã®ææ¬ãšãªãããšãéèŠã§ãã
- å®¶æå šå¡ã§å¥åº·çãªã©ã€ãã¹ã¿ã€ã«ã楜ãã¿ãåã©ãã«ãšã£ãŠè¯ãç°å¢ãäœããŸãããã
- å°å瀟äŒã®æ¯æŽããã°ã©ã ãæŽ»çšããïŒ
- å°åã®å¥åº·æå®€ãåè²ãŠæ¯æŽã»ã³ã¿ãŒãã¹ããŒãã€ãã³ããªã©ã«ç©æ¥µçã«åå ããæ å ±ããµããŒããåŸãŸãããã
- ãããã€ãå»ãä¿å¥åž«ã«å®æçã«çžè«ããåã©ãã®æé·ãå¥åº·ç¶æ ããã§ãã¯ããŠããããŸãããã
ð§ ç ç©¶ã®éçãšä»åŸã®èª²é¡
ãã®ç ç©¶ã¯éèŠãªç¥èŠãæäŸããŸããããããã€ãã®éçãååšããŸãã
- ãã®ç ç©¶ã¯ã暪æç ç©¶ãã§ãããããç¹å®ã®æç¹ã§ã®ç¶æ³ãæãããã®ã§ãããè¥æºã®åå ãšçµæã®é¢ä¿ãçŽæ¥ç¹å®ããããšã¯ã§ããŸãããäŸãã°ããªã女æ§ã§éäœéãå€ãã®ãã瀟äŒçµæžçæ Œå·®ãã©ã®ããã«è¥æºã«ã€ãªããã®ããšãã£ãå æé¢ä¿ãæããã«ããã«ã¯ããããªãç ç©¶ãå¿ èŠã§ãã
- ç 究察象ããã©ã³ã¹åéšã®äžå°åã«éå®ãããŠãããããä»ã®å°åãåœã«çµæãçŽæ¥é©çšããããšã¯é£ããå ŽåããããŸãã
- åã©ãã®é£ç¿æ £ãèº«äœæŽ»åã¬ãã«ãèŠªã®æè²ã¬ãã«ãªã©ãè¥æºã«åœ±é¿ãäžãã詳现ãªèŠå ã«ã€ããŠã¯ããã®ç ç©¶ã§ã¯ååã«ããŒã¿ãåéãããŠããŸããã
ä»åŸã®ç ç©¶ã§ã¯ããããã®éçãå æããåã©ãã®è¥æºã®é·æçãªåŸåãããã詳现ãªèŠå ãæããã«ããããã®ã瞊æç ç©¶ãããå ·äœçãªä»å ¥çã®å¹æãè©äŸ¡ããç ç©¶ãæ±ããããŸãã
ãŸãšã
æ¬ç ç©¶ã¯ãCOVID-19ãã³ãããã¯åŸããã©ã³ã¹åéšã®3ã5æ³å ã«ãããéäœéãšè¥æºã®æç çãå®å®ããŠé«ãæ°Žæºã«ããããšã瀺ããŸãããç¹ã«ã女æ§ã«ãããŠéäœéã®æç çãé«ãããšããããŠç€ŸäŒçµæžçã«äžå©ãªå°åã§è¥æºã®æç çãé¡èã«é«ãããšãæããã«ãªããŸããããããã®çµæã¯ãåã©ãã®è¥æºåé¡ãåãªãå人ã®åé¡ã§ã¯ãªããæ§å·®ã瀟äŒçµæžçæ Œå·®ãšãã£ãè€éãªèŠå ãšæ·±ãé¢é£ããŠããããšã瀺åããŠããŸããä»åŸãå°å瀟äŒå šäœã§é£æºããç¹ã«æ¯æŽãå¿ èŠãªå®¶åºãå°åã«çŠç¹ãåœãŠãããã广çãªäºé²çãè¬ããããšãå«ç·ã®èª²é¡ãšèšããã§ããããç§ãã¡äžäººã²ãšããåã©ãã®å¥åº·çãªæé·ãæ¯ããããã«ãã§ããããšããå§ããŠãããŸãããã
ð é¢é£ãªã³ã¯é
- äžçä¿å¥æ©é¢ïŒWHOïŒ
- åçåŽåçïŒéåã»èº«äœæŽ»å
- æ¥æ¬å°å ç§åŠäŒïŒåã©ãã®å¥åº·ãšäºé²
- åœç«å¥åº·ã»æ é€ç ç©¶æ
æžèªæ å ±
| DOI | 10.1016/j.arcped.2026.105500 |
|---|---|
| PMID | 41807216 |
| PubMed URL | https://pubmed.ncbi.nlm.nih.gov/41807216/ |
| çºè¡å¹Ž | 2026 |
| èè å | Goussard Margot, Lucas Anaïs, Valle Frédéric, Allouche Jonathan, Reynaud Rachel, Champsaur Laurence, Jego Maeva |
| èè æå± | Department of General Practice, Aix Marseille Univ, Marseille, France.; Maternal and Child Protection Department, Conseil départemental des Bouches-du-RhÃŽne, Marseille, France.; Assistance-Publique des HÃŽpitaux de Marseille (AP-HM), Multidisciplinary Pediatric Service - La Timone Children's Hospital, 264 rue Saint Pierre, 13385 Marseille, France.; Department of General Practice, Aix Marseille Univ, Marseille, France; Aix Marseille Univ, CEReSS, EA3279, Marseille, France. Electronic address: Maeva.jego@univ-amu.fr. |
| éèªå | Arch Pediatr |